Sunmax Biotechnology Co., Ltd. (TPEX:4728)

Sunmax Biotechnology Revenue

Sunmax Biotechnology had revenue of 618.26M TWD in the quarter ending June 30, 2026, with 34.37% growth. This brings the company's total for the last twelve months to 2.19B, up 12.50% year-over-year. In the year 2025, Sunmax Biotechnology had annual revenue of 2.03B with 11.45% growth. That makes Sunmax Biotechnology the 25,677th largest company in the world by revenue and 1,156th in Taiwan.

• Revenue (ttm): 2.19B
• Revenue Growth: +12.50%
• P/S Ratio: 9.78
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 21.46B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Mainland China Consolidation Department 1.81B 63.3%
• Taiwan Operating Segment 1.05B 36.7%

By Geography

Chart

• Mainland China 1.81B 89.2%
• Taiwan 182.04M 9.0%
• Others 36.47M 1.8%

Fiscal year ended Dec 31, 2025 See the full Sunmax Biotechnology breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.03B	208.15M	11.45%
Dec 31, 2024	1.82B	129.03M	7.64%
Dec 31, 2023	1.69B	288.91M	20.64%
Dec 31, 2022	1.40B	364.42M	35.19%
Dec 31, 2021	1.04B	179.81M	21.01%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 17, 2026

Data Sources Report a data error